New highly diverse hepatitis C strains detected in sub ‐Saharan Africa have unknown susceptibility to direct‐acting antiviral treatments

ConclusionWhile HCV prevalence and genotypes have been well characterised in patients in well ‐resourced countries, clinical trials are urgently required in SSA where highly diverse g4 and 7 strains circulate.This article is protected by copyright. All rights reserved.

Source: Hepatology - November 2, 2018 Category: Internal Medicine Authors: Chris Davis, George S. Mgomella, Ana da Silva Filipe, Eric H. Frost, Genevieve Giroux, Joseph Hughes, Catherine Hogan, Pontiano Kaleebu, Gershim Asiki, John McLauchlan, Marc Niebel, Ponsiano Ocama, Cristina Pomila, Oliver G. Pybus, Jacques P Tags: Original Article Source Type: research